Fluoresans Algılama Alfa-Synüklein Agregatlar Gut Bir Peptit Probu Kullanarak.
Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe.
DOI: 10.1021/acschemneuro.6c00069PMID: 41771532
Fluorescence Detection of Alpha-Synuclein Aggregates in the Gut Using a Peptide Probe.
DOI: 10.1021/acschemneuro.6c00069PMID: 41771532
Gut ecosystem dysfunction in parkinson's disease: deciphering faecal metabolome-metagenome links for novel diagnostic panels.
DOI: 10.1038/s41531-026-01299-7PMID: 41771902
M[Formula: see text]DGAT: Multi-view multi-scale dynamic graph attention network(GAT) based prediction of Parkinson's disease(PD) progression using whole-blood RNA sequencing data.
DOI: 10.1038/s41598-026-40636-xPMID: 41771960
Anxiety and depression as prodromes of Parkinson's disease: prospective findings from the Moli-sani study.
DOI: 10.1007/s00415-026-13710-7PMID: 41772237
NeuroViOme: a viral orfeome collection for studies of neurodegenerative disease.
DOI: 10.1007/s13365-025-01303-5PMID: 41772317
Risk Adjustment for Alzheimer Disease and Related Dementias in Medicare Advantage and Health Care Experiences.
DOI: 10.1001/jamanetworkopen.2026.1796PMID: 41823963
Relationship between susceptibility to neurodegenerative diseases and genetic factors in populations exposed to mercury in Medellín, Colombia
DOI: 10.7705/biomedica.7634PMID: 41875454
Misfolded Proteins and Cognitive Decline: Mechanistic Insights into Neurodegenerative Disorders.
DOI: 10.3390/neurolint18030048PMID: 41893050
Skin-Based α-Synuclein Deposits Detection Across the Prodromal Continuum of Synucleinopathies: Updated Evidence and Perspectives.
DOI: 10.3390/biom16030376PMID: 41897312
Effect of <i>Serping1</i> siRNA Injection on Dopaminergic Cell Reduction in an MPTP-Induced Parkinson's Disease Mouse Model.
DOI: 10.3390/biomedicines14030569PMID: 41898215
Role of Dual-Phase 18F FP-CIT PET for Subtyping of Multiple System Atrophy.
DOI: 10.1097/rlu.0000000000006280PMID: 41773889
Neurofilament light chain protein exposure contributes to protein aggregation, microgliosis, astrogliosis and neuroinflammation via p38/MK2/NF-κB/CREB1/Nrf2/HO-1 signalling leading to Parkinson's disease.
DOI: 10.1016/j.ijbiomac.2026.151150PMID: 41780778
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.